Nanoparticles-based anti-aging treatment of Alzheimer’s disease

References

• Acharya MM, Christie L-A, Lan ML, et al. (2009). Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells. Proc Natl Acad Sci U S A 106:19150–5.
   PubMed Web of Science ®Google Scholar
• Acosta JC, Banito A, Wuestefeld T, et al. (2013). A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15:978–90.
   PubMed Web of Science ®Google Scholar
• Aducanumab. (2012). LiverTox: clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD). Available at: http://www.ncbi.nlm.nih.gov/books/NBK571858/.
   Google Scholar
• Afonina IS, Müller C, Martin SJ, Beyaert R. (2015). Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42:991–1004.
   PubMed Web of Science ®Google Scholar
• Al-Azzawi S, Masheta D, Guildford AL, et al. (2018). Dendrimeric poly(epsilon-lysine) delivery systems for the enhanced permeability of flurbiprofen across the blood-brain barrier in Alzheimer’s disease. IJMS 19:3224.
   Web of Science ®Google Scholar
• Alexander GC, Emerson S, Kesselheim AS. (2021). Evaluation of aducanumab for Alzheimer disease: scientific evidence and regulatory review involving efficacy, safety, and futility. JAMA 325:1717–8.
   PubMed Web of Science ®Google Scholar
• Al-Mashhadi S, Simpson JE, Heath PR, Medical Research Council Cognitive Function and Ageing Study, et al. (2015). Oxidative glial cell damage associated with white matter lesions in the aging human brain. Brain Pathol 25:565–74.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. (2021). Alzheimer’s disease facts and figures. Alzheimers Dement 17:327–406.
   PubMed Web of Science ®Google Scholar
• Amor C, Feucht J, Leibold J, et al. (2020). Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583:127–32.
   PubMed Web of Science ®Google Scholar
• Atkinson AJ. (2017). Intracerebroventricular drug administration. Transl Clin Pharmacol 25:117–24.
   PubMedGoogle Scholar
• Baker DJ, Wijshake T, Tchkonia T, et al. (2011). Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:232–6.
   PubMed Web of Science ®Google Scholar
• Barbara R, Belletti D, Pederzoli F, et al. (2017). Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates. Int J Pharm 526:413–24.
   PubMed Web of Science ®Google Scholar
• Batista AF, Rody T, Forny-Germano L, et al. (2021). Interleukin-1β mediates alterations in mitochondrial fusion/fission proteins and memory impairment induced by amyloid-β oligomers. J Neuroinflammation 18:54.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Gendelman HE, Kabanov AV. (2011). Cell-mediated drug delivery. Expert Opin Drug Deliv 8:415–33.
   PubMed Web of Science ®Google Scholar
• Bhanu MU, Mandraju RK, Bhaskar C, Kondapi AK. (2010). Cultured cerebellar granule neurons as an in vitro aging model: topoisomerase IIβ as an additional biomarker in DNA repair and aging. Toxicol In Vitro 24:1935–45.
   PubMed Web of Science ®Google Scholar
• Bhat R, Crowe EP, Bitto A, et al. (2012). Astrocyte senescence as a component of Alzheimer’s disease. PLoS One 7:e45069.
   PubMed Web of Science ®Google Scholar
• Bilal M, Barani M, Sabir F, et al. (2020). Nanomaterials for the treatment and diagnosis of Alzheimer’s disease: an overview. NanoImpact 20:100251.
   Web of Science ®Google Scholar
• Binda A, Murano C, Rivolta I. (2020). Innovative therapies and nanomedicine applications for the treatment of Alzheimer’s disease: a State-of-the-Art (2017–2020). Int J Nanomed 15:6113–35.
   PubMed Web of Science ®Google Scholar
• Birch J, Gil J. (2020). Senescence and the SASP: many therapeutic avenues. Genes Dev 34:1565–76.
   PubMed Web of Science ®Google Scholar
• Bitto A, Sell C, Crowe E, et al. (2010). Stress-induced senescence in human and rodent astrocytes. Exp Cell Res 316:2961–8.
   PubMed Web of Science ®Google Scholar
• Bloom GS. (2014). Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505–8.
   PubMed Web of Science ®Google Scholar
• Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ. (2018). The aging astrocyte transcriptome from multiple regions of the mouse brain. Cell Rep 22:269–85.
   PubMed Web of Science ®Google Scholar
• Bourgeois B, Madl T. (2018). Regulation of cellular senescence via the FOXO4-p53 axis. FEBS Lett 592:2083–97.
   PubMed Web of Science ®Google Scholar
• Brookhouser N, Raman S, Potts C, Brafman DA. (2017). May I cut in? Gene editing approaches in human induced pluripotent stem cells. Cells 6:5.
   PubMed Web of Science ®Google Scholar
• Brown WR, Thore CR. (2011). Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37:56–74.
   PubMed Web of Science ®Google Scholar
• Bussian TJ, Aziz A, Meyer CF, et al. (2018). Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562:578–82.
   PubMed Web of Science ®Google Scholar
• Caccamo A, De Pinto V, Messina A, et al. (2014). Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer’s disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature. J Neurosci 34:7988–98.
   PubMed Web of Science ®Google Scholar
• Cai L, Yang C, Jia W, et al. (2020). Endo/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer’s disease. Adv Funct Mater 30:1909999.
   Web of Science ®Google Scholar
• Cai Y, Zhou H, Zhu Y, et al. (2020). Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res 30:574–89.
   PubMed Web of Science ®Google Scholar
• Cai Z, Xiao M. (2016). Oligodendrocytes and Alzheimer’s disease. Int J Neurosci 126:97–104.
   PubMed Web of Science ®Google Scholar
• Campisi J. (2011). Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev 21:107–12.
   PubMed Web of Science ®Google Scholar
• Chae J-B, Jang H, Son C, et al. (2021). Targeting senescent retinal pigment epithelial cells facilitates retinal regeneration in mouse models of age-related macular degeneration. Geroscience 43:2809–33.
   PubMed Web of Science ®Google Scholar
• Childs BG, Durik M, Baker DJ, van Deursen JM. (2015). Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21:1424–35.
   PubMed Web of Science ®Google Scholar
• Childs BG, Gluscevic M, Baker DJ, et al. (2017). Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov 16:718–35.
   PubMed Web of Science ®Google Scholar
• Colacurcio DJ, Nixon RA. (2016). Disorders of lysosomal acidification - the emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev 32:75–88.
   PubMed Web of Science ®Google Scholar
• Communiqué of the Seventh National Population Census (No. 5) [Internet]. Available at: http://www.stats.gov.cn/english/PressRelease/202105/t20210510_1817190.html.
   Google Scholar
• Daneman R, Prat A. (2015). The blood-brain barrier. Cold Spring Harb Perspect Biol 7:a020412.
   PubMed Web of Science ®Google Scholar
• DeRidder L, Sharma A, Liaw K, et al. (2021). Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances β-amyloid phagocytosis. Nanoscale 13:939–52.
   PubMed Web of Science ®Google Scholar
• Dong W, Cheng S, Huang F, et al. (2011). Mitochondrial dysfunction in long-term neuronal cultures mimics changes with aging. Med Sci Monit 17:BR91–96.
   PubMed Web of Science ®Google Scholar
• Duncan T, Valenzuela M. (2017). Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Res Ther 8:111.
   PubMed Web of Science ®Google Scholar
• Effenberger T, von der Heyde J, Bartsch K, et al. (2014). Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding. Faseb J 28:4847–56.
   PubMed Web of Science ®Google Scholar
• Elcioğlu HK, Aslan E, Ahmad S, et al. (2016). Tocilizumab’s effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer’s model. Mol Cell Biochem 420:21–8.
   PubMed Web of Science ®Google Scholar
• Escobar KA, Cole NH, Mermier CM, VanDusseldorp TA. (2019). Autophagy and aging: maintaining the proteome through exercise and caloric restriction. Aging Cell 18:e12876.
   PubMed Web of Science ®Google Scholar
• Fan S, Zheng Y, Liu X, et al. (2018). Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease. Drug Deliv 25:1091–102.
   PubMed Web of Science ®Google Scholar
• Fanoudi S, Hosseini M, Alavi MS, et al. (2018). Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats. Excli J 17:999–1017.
   PubMed Web of Science ®Google Scholar
• Forloni G, Balducci C. (2018). Alzheimer’s disease, oligomers, and inflammation. J Alzheimers Dis 62:1261–76.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Campisi J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69:S4–S9.
   PubMed Web of Science ®Google Scholar
• Fuhrmann-Stroissnigg H, Ling YY, Zhao J, et al. (2017). Identification of HSP90 inhibitors as a novel class of senolytics. Nat Commun 8:422.
   PubMed Web of Science ®Google Scholar
• Furtado D, Björnmalm M, Ayton S, et al. (2018). Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases. Adv Mater 30:e1801362.
   PubMed Web of Science ®Google Scholar
• Gao G, Zhang M, Gong D, et al. (2017). The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation. Nanoscale 9:4107–13.
   PubMed Web of Science ®Google Scholar
• Gao H. (2016). Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 6:268–86.
   PubMed Web of Science ®Google Scholar
• Gao N, Sun H, Dong K, et al. (2015). Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer’s disease. Chemistry 21:829–35.
   PubMed Web of Science ®Google Scholar
• Gao X, Gu X, Chen H. (2017). Chapter 3 - The distribution and elimination of nanomaterials in brain. In: Jiang X, Gao H, eds. Neurotoxicity of nanomaterials and nanomedicine. Academic Press, London/San Diego (CA)/Cambridge (MA)/Oxford, 59–74. Available at: https://www.sciencedirect.com/science/article/pii/B9780128045985000039.
   Google Scholar
• Geng Y-Q, Guan J-T, Xu X-H, Fu Y-C. (2010). Senescence-associated beta-galactosidase activity expression in aging hippocampal neurons. Biochem Biophys Res Commun 396:866–9.
   PubMed Web of Science ®Google Scholar
• Giacci MK, Bartlett CA, Smith NM, et al. (2018). Oligodendroglia are particularly vulnerable to oxidative damage after neurotrauma in vivo. J Neurosci 38:6491–504.
   PubMed Web of Science ®Google Scholar
• Glick D, Barth S, Macleod KF. (2010). Autophagy: cellular and molecular mechanisms. J Pathol 221:3–12.
   PubMed Web of Science ®Google Scholar
• Grimm A, Eckert A. (2017). Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143:418–31.
   PubMed Web of Science ®Google Scholar
• Guerrero A, Herranz N, Sun B, et al. (2019). Cardiac glycosides are broad-spectrum senolytics. Nat Metab 1:1074–88.
   PubMedGoogle Scholar
• Hamano T, Gendron TF, Causevic E, et al. (2008). Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci 27:1119–30.
   PubMed Web of Science ®Google Scholar
• Han F, Bi J, Qiao L, Arancio O. (2020). Stem cell therapy for Alzheimer’s disease. Adv Exp Med Biol 1266:39–55.
   PubMed Web of Science ®Google Scholar
• Hansen M, Rubinsztein DC, Walker DW. (2018). Autophagy as a promoter of longevity: insights from model organisms. Nat Rev Mol Cell Biol 19:579–93.
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. (2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885–9.
   PubMed Web of Science ®Google Scholar
• He N, Jin W-L, Lok K-H, et al. (2013). Amyloid-β(1-42) oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2. Cell Death Dis 4:e924.
   PubMed Web of Science ®Google Scholar
• He X, Wang X, Yang L, et al. (2022). Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer’s disease treatment by anti-neuroinflammation and neuroprotection. Acta Pharm Sin B 12:1987–99.
   PubMed Web of Science ®Google Scholar
• Hebert LE, Bienias JL, Aggarwal NT, et al. (2010). Change in risk of Alzheimer disease over time. Neurology 75:786–91.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, et al. (2015). Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405.
   PubMed Web of Science ®Google Scholar
• Hou K, Zhao J, Wang H, et al. (2020). Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease. Nat Commun 11:4790.
   PubMed Web of Science ®Google Scholar
• Huang J, Tao C, Yu Y, et al. (2016). Simultaneous targeting of differentiated breast cancer cells and breast cancer stem cells by combination of docetaxel- and sulforaphane-loaded self-assembled poly(D, L-lactide-co-glycolide)/hyaluronic acid block copolymer-based nanoparticles. J Biomed Nanotechnol 12:1463–77.
   PubMed Web of Science ®Google Scholar
• Huang N, Lu S, Liu X-G, et al. (2017). PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer’s disease mice. Oncotarget 8:81001–13.
   PubMedGoogle Scholar
• Ishikawa S, Ishikawa F. (2020). Proteostasis failure and cellular senescence in long-term cultured post-mitotic rat neurons. Aging Cell 19:e13071.
   PubMed Web of Science ®Google Scholar
• Jessen KR. (2004). Glial cells. Int J Biochem Cell Biol 36:1861–7.
   PubMed Web of Science ®Google Scholar
• Jia L, Du Y, Chu L, COAST Group, et al. (2020). Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5:e661–e671.
   PubMed Web of Science ®Google Scholar
• Jurk D, Wang C, Miwa S, et al. (2012). Post-mitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11:996–1004.
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, Galvan V. (2019). Rapamycin and Alzheimer’s disease: time for a clinical trial? Sci Transl Med 11:eaar4289.
   PubMed Web of Science ®Google Scholar
• Kannan S, Dai H, Navath RS, et al. (2012). Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 4:130ra46.
   PubMed Web of Science ®Google Scholar
• Kim BYS, Rutka JT, Chan WCW. (2010). Nanomedicine. N Engl J Med 363:2434–43.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Seo SW, Chang JW, et al. (2015). Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase 1 clinical trial. Alzheimers Dement (N Y) 1:95–102.
   PubMedGoogle Scholar
• Kinney JW, Bemiller SM, Murtishaw AS, et al. (2018). Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y) 4:575–90.
   PubMedGoogle Scholar
• Kirkland JL, Tchkonia T. (2020). Senolytic drugs: from discovery to translation. J Intern Med 288:518–36.
   PubMed Web of Science ®Google Scholar
• Knopman DS, Jones DT, Greicius MD. (2021). Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement 17:696–701.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441:880–4.
   PubMed Web of Science ®Google Scholar
• Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. (2020). Flavonoids as anticancer agents. Nutrients 12:457.
   PubMed Web of Science ®Google Scholar
• Kou X, Chen N. (2017). Resveratrol as a natural autophagy regulator for prevention and treatment of Alzheimer’s disease. Nutrients 9:927.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Torrice C, Ramsey MR, et al. (2004). Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299–307.
   PubMed Web of Science ®Google Scholar
• Kritsilis M, V Rizou S, Koutsoudaki PN, et al. (2018). Ageing, cellular senescence and neurodegenerative disease. IJMS 19:2937.
   Web of Science ®Google Scholar
• Kuhn S, Gritti L, Crooks D, Dombrowski Y. (2019). Oligodendrocytes in development, myelin generation and beyond. Cells 8:1424.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. (2017). Curcumin, the golden nutraceutical: multi-targeting for multiple chronic diseases. Br J Pharmacol 174:1325–48.
   PubMed Web of Science ®Google Scholar
• Kuo YC, Chen IY, Rajesh R. (2018). Use of functionalized liposomes loaded with antioxidants to permeate the blood–brain barrier and inhibit β-amyloid-induced neurodegeneration in the brain. J Taiwan Inst Chem Eng 87:1–14.
   Web of Science ®Google Scholar
• Kuo Y-C, Lou Y-I, Rajesh R. (2020). Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons. J Drug Target 28:949–60.
   PubMed Web of Science ®Google Scholar
• Kuo Y-C, Tsao C-W. (2017). Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin. Int J Nanomed 12:2857–69.
   PubMed Web of Science ®Google Scholar
• Kuo Y-C, Tsai H-C. (2018). Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons. Mater Sci Eng C Mater Biol Appl 91:445–57.
   PubMed Web of Science ®Google Scholar
• Lazar AN, Mourtas S, Youssef I, et al. (2013). Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease. Nanomedicine 9:712–21.
   PubMed Web of Science ®Google Scholar
• Lee J-H, McBrayer MK, Wolfe DM, et al. (2015). Presenilin 1 maintains lysosomal Ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep 12:1430–44.
   PubMed Web of Science ®Google Scholar
• Lee J-W, Choi HJ, Kim E-J, et al. (2020). Fisetin induces apoptosis in uterine leiomyomas through multiple pathways. Sci Rep 10:7993.
   PubMed Web of Science ®Google Scholar
• Lei T, Yang Z, Xia X, et al. (2021). A nanocleaner specifically penetrates the blood-brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease. Acta Pharm Sin B 11:4032–44.
   PubMed Web of Science ®Google Scholar
• Li Q, Cao Y, Dang C, et al. (2020). Inhibition of double-strand DNA-sensing cGAS ameliorates brain injury after ischemic stroke. EMBO Mol Med 12:e11002.
   PubMed Web of Science ®Google Scholar
• Li W, Guo Q, Zhao H, et al. (2012). Novel dual-control poly(N-isopropylacrylamide-co-chlorophyllin) nanogels for improving drug release. Nanomedicine (Lond) 7:383–92.
   PubMed Web of Science ®Google Scholar
• Li W, He Y, Zhang R, et al. (2019). The curcumin analog EF24 is a novel senolytic agent. Aging (Albany NY) 11:771–82.
   PubMedGoogle Scholar
• Limbad C, Oron TR, Alimirah F, et al. (2020). Astrocyte senescence promotes glutamate toxicity in cortical neurons. PLoS One 15:e0227887.
   PubMed Web of Science ®Google Scholar
• Lipinski MM, Zheng B, Lu T, et al. (2010). Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer’s disease. Proc Natl Acad Sci U S A 107:14164–9.
   PubMed Web of Science ®Google Scholar
• Liu P, Zhang T, Chen Q, et al. (2021). Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer’s disease by inflammatory microenvironment modulation. Adv Mater 33:e2100746.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li Y, Jiang W, et al. (2016). Inhibition of HSP90 promotes neural stem cell survival from oxidative stress through attenuating NF-κB/p65 activation. Oxid Med Cell Longev 2016:3507290.
   PubMed Web of Science ®Google Scholar
• Liu Y-C, Gao X-X, Chen L, You X-Q. (2017). Rapamycin suppresses Aβ25-35- or LPS-induced neuronal inflammation via modulation of NF-κB signaling. Neuroscience 355:188–99.
   PubMed Web of Science ®Google Scholar
• Livingston G, Huntley J, Sommerlad A, et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413–46.
   PubMed Web of Science ®Google Scholar
• Lopes-Paciencia S, Saint-Germain E, Rowell M-C, et al. (2019). The senescence-associated secretory phenotype and its regulation. Cytokine 117:15–22.
   PubMed Web of Science ®Google Scholar
• Lu Y, Guo Z, Zhang Y, et al. (2019). Microenvironment remodeling micelles for Alzheimer’s disease therapy by early modulation of activated microglia. Adv Sci (Weinh) 6:1801586.
   PubMedGoogle Scholar
• Mathew A, Fukuda T, Nagaoka Y, et al. (2012). Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer’s disease. PLoS One 7:e32616.
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer E, Rogers J, Sibley J. (1990). Anti-inflammatory drugs and Alzheimer disease. Lancet 335:1037.
   PubMed Web of Science ®Google Scholar
• McGeer PL, Rogers J, McGeer EG. (2016). Inflammation, anti-inflammatory agents, and Alzheimer’s disease: the last 22 years. J Alzheimers Dis 54:853–7.
   PubMed Web of Science ®Google Scholar
• McGeer PL, Schulzer M, McGeer EG. (1996). Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47:425–32.
   PubMed Web of Science ®Google Scholar
• McHugh D, Gil J. (2018). Senescence and aging: causes, consequences, and therapeutic avenues. J Cell Biol 217:65–77.
   PubMed Web of Science ®Google Scholar
• Meng F, Asghar S, Gao S, et al. (2015). A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer’s disease. Colloids Surf B Biointerfaces 134:88–97.
   PubMed Web of Science ®Google Scholar
• Mhatre SD, Tsai CA, Rubin AJ, et al. (2015). Microglial malfunction: the third rail in the development of Alzheimer’s disease. Trends Neurosci 38:621–36.
   PubMed Web of Science ®Google Scholar
• Mohamad Anuar NN, Nor Hisam NS, Liew SL, Ugusman A. (2020). Clinical review: navitoclax as a pro-apoptotic and anti-fibrotic agent. Front Pharmacol 11:564108.
   PubMed Web of Science ®Google Scholar
• Moiseeva O, Deschênes-Simard X, St-Germain E, et al. (2013). Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell 12:489–98.
   PubMed Web of Science ®Google Scholar
• Mourtas S, Lazar AN, Markoutsa E, et al. (2014). Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem 80:175–83.
   PubMed Web of Science ®Google Scholar
• Mulik RS, Mönkkönen J, Juvonen RO, et al. (2010). ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol Pharm 7:815–25.
   PubMed Web of Science ®Google Scholar
• Musi N, Valentine JM, Sickora KR, et al. (2018). Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17:e12840.
   PubMed Web of Science ®Google Scholar
• Nalivaeva NN, Turner AJ. (2019). Targeting amyloid clearance in Alzheimer’s disease as a therapeutic strategy. Br J Pharmacol 176:3447–63.
   PubMed Web of Science ®Google Scholar
• Nayak D, Roth TL, McGavern DB. (2014). Microglia development and function. Annu Rev Immunol 32:367–402.
   PubMed Web of Science ®Google Scholar
• Nelson PT, Alafuzoff I, Bigio EH, et al. (2012). Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71:362–81.
   PubMed Web of Science ®Google Scholar
• Neves AR, Queiroz JF, Reis S. (2016). Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J Nanobiotechnol 14:27.
   PubMed Web of Science ®Google Scholar
• Nogueira-Recalde U, Lorenzo-Gómez I, Blanco FJ, et al. (2019). Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine 45:588–605.
   PubMed Web of Science ®Google Scholar
• Ott C, König J, Höhn A, et al. (2016). Macroautophagy is impaired in old murine brain tissue as well as in senescent human fibroblasts. Redox Biol 10:266–73.
   PubMed Web of Science ®Google Scholar
• Palmal S, Maity AR, Singh BK, et al. (2014). Inhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin-gold nanoparticles. Chemistry 20:6184–91.
   PubMed Web of Science ®Google Scholar
• Papisov MI, Belov VV, Gannon KS. (2013). Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS. Mol Pharm 10:1522–32.
   PubMed Web of Science ®Google Scholar
• Park D, Yang Y-H, Bae DK, et al. (2013). Improvement of cognitive function and physical activity of aging mice by human neural stem cells over-expressing choline acetyltransferase. Neurobiol Aging 34:2639–46.
   PubMed Web of Science ®Google Scholar
• Pickford F, Masliah E, Britschgi M, et al. (2008). The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118:2190–9.
   PubMed Web of Science ®Google Scholar
• Picone P, Ditta LA, Sabatino MA, et al. (2016). Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer’s disease. Biomaterials 80:179–94.
   PubMed Web of Science ®Google Scholar
• Piskovatska V, Storey KB, Vaiserman AM, Lushchak O. (2020). The use of metformin to increase the human healthspan. Adv Exp Med Biol 1260:319–32.
   PubMed Web of Science ®Google Scholar
• Prata LGPL, Ovsyannikova IG, Tchkonia T, Kirkland JL. (2018). Senescent cell clearance by the immune system: emerging therapeutic opportunities. Semin Immunol 40:101275.
   PubMedGoogle Scholar
• Price JF, Stewart MC, Deary IJ, AAA Trialists, et al. (2008). Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 337:a1198.
   PubMed Web of Science ®Google Scholar
• Prins ND, Scheltens P. (2015). White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 11:157–65.
   PubMed Web of Science ®Google Scholar
• Ries M, Sastre M. (2016). Mechanisms of Aβ clearance and degradation by glial cells. Front Aging Neurosci 8:160.
   PubMed Web of Science ®Google Scholar
• Ross C, Taylor M, Fullwood N, Allsop D. (2018). Liposome delivery systems for the treatment of Alzheimer’s disease. Int J Nanomed 13:8507–22.
   PubMed Web of Science ®Google Scholar
• Ruan S, Zhou Y, Jiang X, Gao H. (2021). Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release. Adv Sci (Weinh) 8:2004025.
   PubMedGoogle Scholar
• Sarkar S, Floto RA, Berger Z, et al. (2005). Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170:1101–11.
   PubMed Web of Science ®Google Scholar
• Sengupta U, Nilson AN, Kayed R. (2016). The role of amyloid-β oligomers in toxicity, propagation, and immunotherapy. EBioMedicine 6:42–9.
   PubMed Web of Science ®Google Scholar
• Shah S, Rangaraj N, Laxmikeshav K, Sampathi S. (2020). Nanogels as drug carriers - Introduction, chemical aspects, release mechanisms and potential applications. Int J Pharm 581:119268.
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee YS. (2013). Molecular mechanisms of curcumin action: signal transduction. Biofactors 39:27–36.
   PubMed Web of Science ®Google Scholar
• Shook BA, Manz DH, Peters JJ, et al. (2012). Spatiotemporal changes to the subventricular zone stem cell pool through aging. J Neurosci 32:6947–56.
   PubMed Web of Science ®Google Scholar
• Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. (2007). Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55:412–24.
   PubMed Web of Science ®Google Scholar
• Sochocka M, Donskow-Łysoniewska K, Diniz BS, et al. (2019). The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease - a critical review. Mol Neurobiol 56:1841–51.
   PubMed Web of Science ®Google Scholar
• Soenen SJ, Rivera-Gil P, Montenegro JM, et al. (2011). Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 6:446–65.
   Web of Science ®Google Scholar
• Son SM, Shin H-J, Byun J, et al. (2016). Metformin facilitates amyloid-β generation by β- and γ-secretases via autophagy activation. J Alzheimers Dis 51:1197–208.
   PubMed Web of Science ®Google Scholar
• Song S, Lam EW-F, Tchkonia T, et al. (2020). Senescent cells: emerging targets for human aging and age-related diseases. Trends Biochem Sci 45:578–92.
   PubMed Web of Science ®Google Scholar
• Srinivasan K, Friedman BA, Etxeberria A, et al. (2020). Alzheimer’s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep 31:107843.
   PubMed Web of Science ®Google Scholar
• Steele JW, Gandy S. (2013). Latrepirdine (Dimebon®), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model. Autophagy 9:617–8.
   PubMed Web of Science ®Google Scholar
• Su X, Song H, Niu F, et al. (2015). Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. Nanomedicine (Lond) 10:2033–50.
   PubMed Web of Science ®Google Scholar
• Sun Y, Coppé J-P, Lam EW-F. (2018). Cellular senescence: the sought or the unwanted? Trends Mol Med 24:871–85.
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Sagare AP, Zlokovic BV. (2018). Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133–50.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–76.
   PubMed Web of Science ®Google Scholar
• Tiwari SK, Agarwal S, Seth B, et al. (2014). Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano 8:76–103.
   PubMed Web of Science ®Google Scholar
• Triana-Martínez F, Picallos-Rabina P, Da Silva-Álvarez S, et al. (2019). Identification and characterization of Cardiac Glycosides as senolytic compounds. Nat Commun 10:4731.
   PubMed Web of Science ®Google Scholar
• Vaz M, Silvestre S. (2020). Alzheimer’s disease: recent treatment strategies. Eur J Pharmacol 887:173554.
   PubMed Web of Science ®Google Scholar
• Verkhratsky A, Nedergaard M. (2018). Physiology of astroglia. Physiol Rev 98:239–389.
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Chandakkar P, Zhao H, et al. (2011). Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. Faseb J 25:219–31.
   PubMed Web of Science ®Google Scholar
• Wang F, Ren S-Y, Chen J-F, et al. (2020). Myelin degeneration and diminished myelin renewal contribute to age-related deficits in memory. Nat Neurosci 23:481–6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chang J, Liu X, et al. (2016). Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY) 8:2915–26.
   PubMedGoogle Scholar
• Wang Y, Pang J, Wang Q, et al. (2021). Delivering antisense oligonucleotides across the blood-brain barrier by tumor cell-derived small apoptotic bodies. Adv Sci (Weinh) 8:2004929.
   PubMedGoogle Scholar
• Watanabe Y, Taguchi K, Tanaka M. (2020). Ubiquitin, autophagy and neurodegenerative diseases. Cells 9:2022.
   PubMed Web of Science ®Google Scholar
• Wong KH, Riaz MK, Xie Y, et al. (2019). Review of current strategies for delivering Alzheimer’s disease drugs across the blood-brain barrier. IJMS 20:381.
   Web of Science ®Google Scholar
• Xie XP, Laks DR, Sun D, et al. (2020). High-resolution mouse subventricular zone stem-cell niche transcriptome reveals features of lineage, anatomy, and aging. Proc Natl Acad Sci U S A 117:31448–58.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Baker DJ, Tachibana M, et al. (2016). Vascular cell senescence contributes to blood-brain barrier breakdown. Stroke 47:1068–77.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Kanekiyo T. (2017). Blood-brain barrier dysfunction and the pathogenesis of Alzheimer’s disease. IJMS 18:1965.
   Web of Science ®Google Scholar
• Yeh FL, Wang Y, Tom I, et al. (2016). TREM2 binds to apolipoproteins, including APOE and CLU/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91:328–40.
   PubMed Web of Science ®Google Scholar
• Yu H-M, Zhao Y-M, Luo X-G, et al. (2012). Repeated lipopolysaccharide stimulation induces cellular senescence in BV2 cells. Neuroimmunomodulation 19:131–6.
   PubMed Web of Science ®Google Scholar
• Zandi PP, Anthony JC, Hayden KM, Cache County Study Investigators, et al. (2002). Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County study. Neurology 59:880–6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang L, Wang R, et al. (2017). Evaluating the effectiveness of GTM-1, rapamycin, and carbamazepine on autophagy and Alzheimer disease. Med Sci Monit 23:801–8.
   PubMed Web of Science ®Google Scholar
• Zhang P, Kishimoto Y, Grammatikakis I, et al. (2019). Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model. Nat Neurosci 22:719–28.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Doornebal EJ, Pirtskhalava T, et al. (2017). New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) 9:955–63.
   PubMedGoogle Scholar